UBS AM
ASXC

UBS AM’s Asensus Surgical, Inc. ASXC Stock Holding History

UBS AM’s Portfolio ASXC Stock Details ASXC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		– Sell
-7,615
Closed -$61.4K – 2893
2019
Q3 		$61.4K Buy
7,615
+1,474
+24% +$20K ﹤0.01% 2702
2019
Q2 		$109K Hold
6,141
– – ﹤0.01% 2636
2019
Q1 		$190K Sell
6,141
-2,993
-33% -$100K ﹤0.01% 2474
2018
Q4 		$268K Buy
+9,134
New +$415K ﹤0.01% 2263

Other funds holding ASXC

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
First Trust Advisors
First Trust Advisors Wheaton, Illinois $140B AUM 27.84% 1-Year Est. Return
SHI
SV Health Investors Boston, Massachusetts $32.3M AUM 20.15% 1-Year Est. Return
Mirae Asset Global Investments
Mirae Asset Global Investments Seoul, South Korea $67.7B AUM 51.91% 1-Year Est. Return
MCM
Masters Capital Management Atlanta, Georgia $3.03B AUM 57.21% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

UBS AM's ASXC Position: Q4 2019 in Review

UBS AM sold out of Asensus Surgical, Inc. (ASXC) in Q4 2019, closing a stake of 7,615 shares — an estimated $61.4K sold.

UBS AM first reported a position in ASXC in Q4 2018 and held it in 4 quarters. The position peaked at $268K in Q4 2018. 81 funds tracked by Wall St. Rank hold ASXC as of Q4 2019.

  • UBS AM reported no remaining Asensus Surgical, Inc. position as of Q4 2019 after selling out during the quarter.
  • UBS AM sold 7,615 Asensus Surgical, Inc. shares in Q4 2019, an estimated $61.4K.
  • UBS AM first reported a position in Asensus Surgical, Inc. in Q4 2018 and held it in 4 quarters.
  • UBS AM's Asensus Surgical, Inc. position peaked at $268K in Q4 2018.
  • 81 funds tracked by Wall St. Rank held Asensus Surgical, Inc. as of Q4 2019.

Based on UBS AM's 13F filing for Q4 2019, filed 14 Feb 2020.